Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
This will ensure your comfort and confidence with the weight loss medication before you begin
Join us at the 20th Annual CMHC for comprehensive FDA updates, instructive patient case studies, late-breaking trial data, and more
For best results, continue daily use for 3-6 months
Overall, these analyses indicate that while there may be trends in the data, demographic factors such as age and sex do not appear to significantly influence WL or WR outcomes following GLP-1RAs therapy or bariatric surgery
CT-388 (enicepatide), a dual GLP-1/GIP injectable, delivered 22.5% weight loss in Phase 2 with 54% of patients on the highest dose achieving a BMI under 30
US$ 28.42
US$ 24.60
US$ 23.66
US$ 22.21
US$ 22.59
US$ 27.49
US$ 27.05
US$ 29.67
US$ 27.14
US$ 27.88
US$ 23.34
US$ 27.13
US$ 23.54
